Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
802.95
Change Change %
-12.35 -1.51%

Updated:12 Nov, 2018, 14:59 PM IST

BSE
796.50
Change Change %
-16.80 -2.07%

Updated:12 Nov, 2018, 15:18 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
11-08-2014 Buy 753.25 915.00
N/A
Target Hit Long (1Y)
11-08-2015

Bank of America Merrill Lynch maintains buy on Aurobindo Pharma

Raising FY15 and FY16 earnings per share estimates by 5 per cent and 4 per cent. US sales hit an all-time high of $187 million in the June quarter. Improving profitability will continue to drive re-rating. Expect margins to remain at 23-24 per cent levels.

Top